Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/11/19 → 5/11/24 |
Keywords
- Clinical trial
- phase 1 and 2 study
- treatment efficacy
- haematological malignancy
A Phase 1/Phase 2 Clinical Study to Evaluate the Safety and Efficacy of a Combination of MK-4280 and Pembrolizumab (MK-3475) in Participants with Hematologic Malignancies
- Gregory, Gareth (Primary Chief Investigator (PCI))
Project: Research